MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Genome-wide association study of Aβ, t-tau and p-tau in CSF in Parkinson’s disease

    H. Iwaki (Bethesda, USA)

    Objective: To investigate genetic contributions to the Alzheimer’s disease (AD) related cerebrospinal fluid (CSF) biomarkers in the patients with Parkinson’s disease (PD). Background: Aβ, t-tau…
  • 2022 International Congress

    An unusual cause of choreoathetosis: PRES and Goodpasture’s Syndrome

    M. Bonello, M. Cauchi, R. Debono, N. Vella (Pieta, Malta)

    Objective: Our aim is to shed light on an usual cause of choreoathetosis in a medically complex case. Background: Goodpasture’s syndrome(GBS) is a rare autoimmune…
  • 2022 International Congress

    Clinically interpretable severity estimation of facial expression impairment in Parkinson’s disease

    Y. Dushin, G. Morinan, G. Sarapata, J. O'Keeffe (London, United Kingdom)

    Objective: To develop a scalable and interpretable computer-vision based algorithm to measure the severity of facial impairment in Parkinson’s disease. Background: Neurological disorders frequently manifest…
  • 2022 International Congress

    Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Incremental Motor Improvement Observed with Increasing Doses

    S. Isaacson, I. Zhang, E. Pappert, A. Bowling (Boca Raton, USA)

    Objective: Evaluate magnitude of motor improvement with increasing doses of apomorphine sublingual film (SL-APO) in patients with Parkinson’s disease (PD) and OFF episodes. Background: Identifying…
  • 2022 International Congress

    Assessment of mood symptoms and influence on disease in cervical dystonia

    S. Rafee, S. O'Riordan, M. Hutchinson (Dublin, Ireland)

    Objective: To compare mood symptom rating scales and influence of anxiety and depressive symptoms on motor severity and aspects of quality of life. Background: Cervical…
  • 2022 International Congress

    Asymmetry of Motor and Non-motor Signs in Parkinson’s Disease: An Exploratory Clinical Case-control Study

    F. Hansen, N. Okkels, P. Borghammer (Aarhus N, Denmark)

    Objective: To identify, quantify and correlate asymmetry between motor and non-motor signs in early Parkinson’s disease (PD). Background: Asymmetry of motor signs in PD reflects…
  • 2022 International Congress

    Swimming against the current: Successful implementation of functional neurosurgery programs in underserved regions of Chile

    M. Contreras Pinto, J. Hortal, G. Fernandez (la serena, Chile)

    Objective: To show the experience of implementing a functional neurosurgery program with Deep Brain Stimulation (DBS) for patients with Parkinson's Disease (PD), in low-income regions…
  • 2022 International Congress

    Oligomeric alpha-synuclein in reflex tears and retinal changes in Parkinson’s disease

    A. Camacho-Ordonez, M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Hernández-Medrano, S. Somilleda-Ventura, H. Perez-Cano, O. Guerrero-Berger (Mexico, Mexico)

    Objective: To compare oligomeric alpha-synuclein (α-Syn) in reflex tears and its association with the thickness of retinal layers in Parkinson’s disease (PD) Background: Alpha-synuclein is…
  • 2022 International Congress

    The Rostock International Parkinson’s Disease (ROPAD) Study: Analysis of Monogenic PD Genes

    A. Westenberger, V. Skrahina, C. Beetz, T. Usnich, E-J. Vollstedt, X. Bogdanovic, N. Schell, M. Olmedillas, F. Curado, J. Paul, S. Skobalj, N. Brüggemann, N. Ameziane, I. Csoti, M. Kasten, C. Klein, P. Bauer, A. Rolfs (Lübeck, Germany)

    Objective: The ROPAD study aims to investigate the frequency and spectrum of Parkinson’s disease (PD) genetic causes across a multitude of PD and other movement…
  • 2022 International Congress

    Opicapone use in patients with Parkinson’s disease with motor fluctuations: experience from a tertiary center

    E. Ojeda-Lepe, L. Muñoz-Delgado, S. Jesús, AD. Adarmes-Gómez, D. Macías-García, MV. Jiménez Jaraba, B. Benítez Zamora, F. Carrillo, P. Mir (Seville, Spain)

    Objective: To assess effectiveness and safety profile of Opicapone in our cohort of patients with Parkinson’s disease (PD) who received this treatment. Background: Opicapone is…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley